WARNING Contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience any of the following: Severe nausea and/or vomiting resulting in dehydration it is important to stay well hydrated and drink plenty of fluids while on this medication
We take these factors into account, especially when recommending platforms for people with type 2 diabetes
Common gastrointestinal complaints like nausea and vomiting are typical early with GLP-1 agonists, often diminishing over weeks with dose titration and regular monitoring
People with existing kidney conditions If you have chronic kidney disease (CKD), any change in urination warrants closer monitoring
A comprehensive investigation of biochemical status in patients with telogen effluvium
Published online July 1, 2025 DOI: 71,412 View 1,817 Download 34 Web of Science 46 Crossref Abstract PDFPubReader ePub Although glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have demonstrated considerable efficacy in the treatment of diabetes and obesity, it is essential to recognize that their use is associated with certain intrinsic risks that must not be disregarded
.jpg)
